Suchergebnisse - %22COVID%22

PubPharm (322)

1

Exploiting high-energy hydration sites for the discovery of potent peptide aldehyde inhibitors of the SARS-CoV-2 main protease with cellular antiviral activity

enthalten in: Bioorganic & medicinal chemistry | 2024

von Carney, D. | Leffler, A. | Bell, J. | +17

2

Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors

enthalten in: Antiviral research | 2024

von Khatua, K. | Alugubelli, Y. | Yang, K. | +17

3

Sensitive detection of SARS-CoV-2 main protease 3CLpro with an engineered ribonuclease zymogen

enthalten in: Protein science : a publication of the Protein Society | 2024

von Wralstad, E. | Raines, R.

4

Manidipine is not a potential inhibitor against SARS-CoV-2 main protease

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Zhang, R. | Zhou, J. | Yan, H. | +3

5

SAR, Molecular Docking and Molecular Dynamic Simulation of Natural Inhibitors against SARS-CoV-2 Mpro Spike Protein

enthalten in: Molecules (Basel, Switzerland) | 2024

von Salamat, A. | Kosar, N. | Mohyuddin, A. | +3

6

In-silico guided design, screening, and molecular dynamic simulation studies for the identification of potential SARS-CoV-2 main protease inhibitors for the targeted treatment of COVID-19

enthalten in: Journal of biomolecular structure & dynamics | 2024

von Gutti, G. | He, Y. | Coldren, W. | +5

7

Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19

enthalten in: Med (New York, N.Y.) | 2024

von Mao, L. | Shaabani, N. | Zhang, X. | +38

ErratumIn: Med. 2024 Feb 9;5(2):169-171. - PMID 38340710

8

Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors

enthalten in: International journal of molecular sciences | 2024

von De Luca, V. | Angeli, A. | Nocentini, A. | +7

9

Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19)

enthalten in: Current medicinal chemistry | 2024

von De, S.

10

Discovery of highly potent covalent SARS-CoV-2 3CLpro inhibitors bearing 2-sulfoxyl-1,3,4-oxadiazole scaffold for combating COVID-19

enthalten in: European journal of medicinal chemistry | 2023

von Zhang, F. | Huang, T. | Wang, F. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]